Breaking News

Tweet TWEET

Wolf Haldenstein Announces Investigation of Unilife Corp.

  Wolf Haldenstein Announces Investigation of Unilife Corp.

Business Wire

NEW YORK -- November 11, 2013

Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a leading
securities law firm, announces that it is investigating claims of misconduct
by the senior management and Board of Directors of Unilife Corp.
(NASDAQ:UNIS). Wolf Haldenstein believes that possible malfeasance by the
senior management and Board of Directors has caused and will continue to cause
Unilife Corp. and its shareholders significant harm.

The investigation concerns whether members of senior management and the Board
of Directors breached their fiduciary duties to the Company and to
shareholders by disseminating false information and attempting to mislead
investors and the market in contravention of federal securities laws. Wolf
Haldenstein is also investigating potential violations of Food and Drug
Administration regulations and claims of corporate waste and mismanagement by
Unilife Corp.’s senior management and Board of Directors.

A complaint has been filed in the United States District Court for the Middle
District of Pennsylvania on behalf of all persons or entities that purchased
the common stock of Unilife Corporation (“between July 13, 2011 and September
9, 2013, inclusive alleging violations of the Securities Exchange Act of 1934
against the Company and certain of its officers (the “Complaint”).

If you wish to serve as lead plaintiff, you must move the Court no later than
December 31, 2013. A lead plaintiff is a representative party acting on behalf
of other class members in directing the litigation. In order to be appointed
lead plaintiff, the Court must determine that the class member’s claim is
typical of the claims of other class members, and that the class member will
adequately represent the class. Your ability to share in any recovery is not,
however, affected by the decision whether or not to serve as a lead plaintiff.
Any member of the proposed class may move the court to serve as lead plaintiff
through counsel of their choice, or may choose to do nothing and remain an
absent class member.

While Wolf Haldenstein did not file the Complaint in this matter, the firm,
with offices in New York, Chicago and San Diego and currently celebrating its
125^th year of providing exemplary legal services to its clients, has
represented individual and institutional investors for many years, serving as
lead counsel in numerous cases in United States federal and state courts.
Please visit the Wolf Haldenstein website (http://www.whafh.com) for more
information about the firm and its attorneys.

If you are a shareholder of Unilife Corp. (NASDAQ: UNIS) who purchased shares
between July 13, 2011 and September 9, 2013 and have suffered a loss, and wish
to discuss this action or have any questions concerning this notice or your
rights or interests please contact us at:

Gregory M. Nespole, Esq.
Wolf Haldenstein Adler Freeman & Herz LLP
270 Madison Avenue
New York, New York 10016
Phone Numbers:
(800) 575-0735
(212) 545-4657
(917) 515-6161

Email:
Classmember@whafh.com or nespole@whafh.com and please reference “Unilife
Corp.”

Attorney Advertising. Prior results do not guarantee a similar outcome

Contact:

Wolf Haldenstein Adler Freeman & Herz LLP
Gregory M. Nespole, Esq.
800-575-0735
212-545-4657
917-515-6161
Classmember@whafh.com
or
nespole@whafh.com
 
Press spacebar to pause and continue. Press esc to stop.